Chimerix reported $119.15M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Ardelyx ARDX:US $ 117.57M 13.24M
Chimerix CMRX:US $ 119.15M 14.5M
Curis CRIS:US $ 112.47M 9.44M
Dynavax Technologies DVAX:US $ 83.38M 16.38M
Emergent Biosolutions EBS:US $ 1543.7M 20.9M
Epizyme EPZM:US $ 67.63M 55.4M
Gilead Sciences GILD:US $ 19710M 758M
Glaxosmithkline GSK:US $ 15377M 512M
Life Technologies LIFE:US $ 40.98M 8.73M
Mirati Therapeutics MRTX:US $ 1128.92M 130.49M
Novavax NVAX:US $ 745.56M 293.56M
Xoma XOMA:US $ 116.58M 34.86M